249 related articles for article (PubMed ID: 32696315)
1. Associations of plasma brain-derived neurotrophic factor (BDNF) and Val66Met polymorphism (rs6265) with long-term cancer-related cognitive impairment in survivors of breast cancer.
Yap NY; Tan NYT; Tan CJ; Loh KW; Ng RCH; Ho HK; Chan A
Breast Cancer Res Treat; 2020 Oct; 183(3):683-696. PubMed ID: 32696315
[TBL] [Abstract][Full Text] [Related]
2. Replication and Meta-analysis of the Association between BDNF Val66Met Polymorphism and Cognitive Impairment in Patients Receiving Chemotherapy.
Tan CJ; Lim SWT; Toh YL; Ng T; Yeo A; Shwe M; Foo KM; Chu P; Jain A; Koo SL; Dent RA; Ng RCH; Yap YS; Lim EH; Loh KW; Chay WY; Lee GE; Tan TJY; Beh SY; Wong M; Chan JJ; Khor CC; Ho HK; Chan A
Mol Neurobiol; 2019 Jul; 56(7):4741-4750. PubMed ID: 30382534
[TBL] [Abstract][Full Text] [Related]
3. Associations of brain-derived neurotrophic factor rs6265 polymorphism and cognitive function in breast cancer survivors from a cross-sectional study.
Goto T; Saligan LN; Li X; Xiang L; Kwiat C; Nguyen C; Crouch A; Von Ah D
Cancer Med; 2024 Jan; 13(2):e6975. PubMed ID: 38379321
[TBL] [Abstract][Full Text] [Related]
4. Brain-derived neurotrophic factor genetic polymorphism (rs6265) is protective against chemotherapy-associated cognitive impairment in patients with early-stage breast cancer.
Ng T; Teo SM; Yeo HL; Shwe M; Gan YX; Cheung YT; Foo KM; Cham MT; Lee JA; Tan YP; Fan G; Yong WS; Preetha M; Loh WJ; Koo SL; Jain A; Lee GE; Wong M; Dent R; Yap YS; Ng R; Khor CC; Ho HK; Chan A
Neuro Oncol; 2016 Feb; 18(2):244-51. PubMed ID: 26289590
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of plasma brain-derived neurotrophic factor levels and self-perceived cognitive impairment post-chemotherapy: a longitudinal study.
Ng T; Lee YY; Chae JW; Yeo AHL; Shwe M; Gan YX; Ng RCH; Chu PPY; Khor CC; Ho HK; Chan A
BMC Cancer; 2017 Dec; 17(1):867. PubMed ID: 29258453
[TBL] [Abstract][Full Text] [Related]
6. Relationship between cytokines and brain-derived neurotrophic factor (BDNF) in trajectories of cancer-related cognitive impairment.
Yap NY; Toh YL; Tan CJ; Acharya MM; Chan A
Cytokine; 2021 Aug; 144():155556. PubMed ID: 33985854
[TBL] [Abstract][Full Text] [Related]
7. Associations between brain-derived neurotrophic factor and cognitive impairment in panic disorder.
Wang W; Liu Y; Luo S; Guo X; Luo X; Zhang Y
Brain Behav; 2020 Dec; 10(12):e01885. PubMed ID: 33047489
[TBL] [Abstract][Full Text] [Related]
8. Evidence of brain-derived neurotrophic factor in ameliorating cancer-related cognitive impairment: A systematic review of human studies.
Ng DQ; Chan D; Agrawal P; Zhao W; Xu X; Acharya M; Chan A
Crit Rev Oncol Hematol; 2022 Aug; 176():103748. PubMed ID: 35718064
[TBL] [Abstract][Full Text] [Related]
9. Functional rs6265 polymorphism in the brain-derived neurotrophic factor gene confers protection against neurocognitive dysfunction in posttraumatic stress disorder among Chinese patients with hepatocellular carcinoma.
Guo JC; Yang YJ; Zheng JF; Guo M; Wang XD; Gao YS; Fu LQ; Jiang XL; Fu LM; Huang T
J Cell Biochem; 2019 Jun; 120(6):10434-10443. PubMed ID: 30659644
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Acupuncture Therapy for Chemotherapy-Related Cognitive Impairment in Breast Cancer Patients.
Tong T; Pei C; Chen J; Lv Q; Zhang F; Cheng Z
Med Sci Monit; 2018 May; 24():2919-2927. PubMed ID: 29735975
[TBL] [Abstract][Full Text] [Related]
11. A protective effect of the BDNF Met/Met genotype in obesity in healthy Caucasian subjects but not in patients with coronary heart disease.
Sustar A; Nikolac Perkovic M; Nedic Erjavec G; Svob Strac D; Pivac N
Eur Rev Med Pharmacol Sci; 2016 Aug; 20(16):3417-26. PubMed ID: 27608901
[TBL] [Abstract][Full Text] [Related]
12. Val66Met BDNF polymorphism as a vulnerability factor for inflammation-associated depressive symptoms in women with breast cancer.
Dooley LN; Ganz PA; Cole SW; Crespi CM; Bower JE
J Affect Disord; 2016 Jun; 197():43-50. PubMed ID: 26967918
[TBL] [Abstract][Full Text] [Related]
13. Brain-derived neurotrophic factor Val66Met polymorphism is associated with mild cognitive impairment in elderly patients with type 2 diabetes: a case-controlled study.
Liu J; Yang W; Luo H; Ma Y; Zhao H; Dan X
Aging Clin Exp Res; 2021 Jun; 33(6):1659-1666. PubMed ID: 32892314
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal evaluation of dehydroepiandrosterone (DHEA), its sulfated form and estradiol with cancer-related cognitive impairment in early-stage breast cancer patients receiving chemotherapy.
Toh YL; Tan CJ; Yap NY; Parajuli R; Lau AJ; Chan A
Sci Rep; 2022 Oct; 12(1):16552. PubMed ID: 36192413
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in the brain-derived neurotrophic factor gene influence memory and processing speed one month after brain injury.
McAllister TW; Tyler AL; Flashman LA; Rhodes CH; McDonald BC; Saykin AJ; Tosteson TD; Tsongalis GJ; Moore JH
J Neurotrauma; 2012 Apr; 29(6):1111-8. PubMed ID: 22188054
[TBL] [Abstract][Full Text] [Related]
16. The Brain-Derived Neurotrophic Factor Functional Polymorphism and Hand Grip Strength Impact the Association between Brain-Derived Neurotrophic Factor Levels and Cognition in Older Adults in the United States.
Liu T; Li H; Conley YP; Primack BA; Wang J; Li C
Biol Res Nurs; 2022 Apr; 24(2):226-234. PubMed ID: 34974714
[TBL] [Abstract][Full Text] [Related]
17. Brain-derived neurotrophic factor as a biomarker in cancer-related cognitive impairment among adolescent and young adult cancer patients.
Ng DQ; Cheng I; Wang C; Tan CJ; Toh YL; Koh YQ; Ke Y; Foo KM; Chan RJ; Ho HK; Chew L; Bin Harunal Rashid MF; Chan A
Sci Rep; 2023 Sep; 13(1):16298. PubMed ID: 37770565
[TBL] [Abstract][Full Text] [Related]
18. Association of mitochondrial DNA content in peripheral blood with cancer-related fatigue and chemotherapy-related cognitive impairment in early-stage breast cancer patients: a prospective cohort study.
Chae JW; Chua PS; Ng T; Yeo AHL; Shwe M; Gan YX; Dorajoo S; Foo KM; Loh KW; Koo SL; Chay WY; Tan TJY; Beh SY; Lim EH; Lee GE; Dent R; Yap YS; Ng R; Ho HK; Chan A
Breast Cancer Res Treat; 2018 Apr; 168(3):713-721. PubMed ID: 29313215
[TBL] [Abstract][Full Text] [Related]
19. Catechol-O-Methyltransferase Gene Polymorphisms and the Risk of Chemotherapy-Induced Prospective Memory Impairment in Breast Cancer Patients with Varying Tumor Hormonal Receptor Expression.
Li W; Zhao J; Ding K; Chao HH; Li CR; Cheng H; Shen L
Med Sci Monit; 2020 Sep; 26():e923567. PubMed ID: 32985495
[TBL] [Abstract][Full Text] [Related]
20. Association between BDNF rs6265 polymorphisms and postoperative cognitive dysfunction in Chinese Han Population.
Xie S; Yu L; Zhou M; Liu L; Lei D; Han C
Brain Behav; 2020 Oct; 10(10):e01800. PubMed ID: 33405375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
